Heinzen R A, Howe D, Mallavia L P, Rockey D D, Hackstadt T
Laboratory of Intracellular Parasites, National Institute of Allergy and Infectious Disease, National Institutes of Health, Rocky Mountain Laboratories, Hamilton, Montana, USA.
Mol Microbiol. 1996 Oct;22(1):9-19. doi: 10.1111/j.1365-2958.1996.tb02651.x.
Coxiella burnetii undergoes a poorly defined developmental cycle within phagolysosomes of eukaryotic host cells. Two distinct developmental forms are part of this cycle: a small-cell variant (SCV) and large-cell variant (LCV). Ultrastructurally, the SCV is distinguished from the LCV by its smaller size and condensed chromatin. At a molecular level, little is known about morphogenesis in C. burnetii, and no proteins specific to the SCV have been identified. Preparative isoelectric focusing was conducted to purify basic proteins possibly involved in SCV chromatin structure. A predominant protein of low M(r) was present in the most basic fraction, eluting with a pH of approx. 11. Degenerate deoxyoligonucleotides corresponding to the N-terminal sequence of this protein were used to recover a cosmid clone from a C. burnetii genomic library. Nucleotide sequencing of insert DNA revealed an open reading frame designated scvA (Small-Cell-variant protein A) with coding potential for a 30 amino acid protein (ScvA) with a predicted M(r) of 3610. ScvA is 46% arginine plus 46% glutamine with a predicted pl of 12.6. SDS-PAGE and silver staining of lysates of SCV and LCV purified by caesium chloride-equilibrium density centrifugation revealed a number of proteins unique to each cell type. Immunoblot analysis with ScvA antiserum demonstrated the presence of ScvA only in the SCV. By Immunoelectron microscopy, ScvA antiserum labelled only the SCV, with the label concentrated on the condensed nucleoid. In addition, ScvA bound double-stranded DNA in gel mobility-shift assays. A 66% reduction in the mean number of gold particles per Coxiella call was observed at 12 h post-infection when compared with the starting inoculum. Collectively, these data suggest that synthesis of ScvA is developmentally regulated, and that the protein may serve a structural or functional role as an integral component of the SCV chromatin. Moreover, degradation of this protein may be a necessary prerequisite for morphogenesis from SCV to LCV.
伯氏考克斯体在真核宿主细胞的吞噬溶酶体内经历一个定义不明确的发育周期。该周期包含两种不同的发育形式:小细胞变体(SCV)和大细胞变体(LCV)。在超微结构上,SCV与LCV的区别在于其尺寸较小且染色质浓缩。在分子水平上,关于伯氏考克斯体的形态发生知之甚少,尚未鉴定出SCV特有的蛋白质。进行制备性等电聚焦以纯化可能参与SCV染色质结构的碱性蛋白质。在最碱性的组分中存在一种低分子量的主要蛋白质,其在pH约为11时洗脱。与该蛋白质N端序列对应的简并脱氧寡核苷酸用于从伯氏考克斯体基因组文库中回收一个黏粒克隆。插入DNA的核苷酸测序揭示了一个开放阅读框,命名为scvA(小细胞变体蛋白A),其编码潜力为一个30个氨基酸的蛋白质(ScvA),预测分子量为3610。ScvA含有46%的精氨酸加46%的谷氨酰胺,预测的等电点为12.6。通过氯化铯平衡密度离心纯化的SCV和LCV裂解物的SDS-PAGE和银染显示每种细胞类型都有一些独特的蛋白质。用ScvA抗血清进行免疫印迹分析表明ScvA仅存在于SCV中。通过免疫电子显微镜,ScvA抗血清仅标记SCV,标记集中在浓缩的类核上。此外,在凝胶迁移率变动分析中ScvA与双链DNA结合。与起始接种物相比,感染后12小时观察到每个考克斯体细胞的金颗粒平均数减少了66%。总体而言,这些数据表明ScvA的合成受发育调控,并且该蛋白质可能作为SCV染色质的一个组成部分发挥结构或功能作用。此外,该蛋白质的降解可能是从SCV向LCV形态发生的必要前提。